XML 125 R91.htm IDEA: XBRL DOCUMENT v3.25.1
Commitments and Contingencies (Details)
12 Months Ended
May 23, 2023
shares
Oct. 25, 2017
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2024
CNY (¥)
Dec. 31, 2023
USD ($)
Apr. 06, 2022
Commitments and Contingencies [Line Items]            
Cash payment     $ 2,856,309   $ 285,400  
Loans payable   $ 100,000        
Shares of common stock (in Shares) | shares 5,000          
Litigation amount     $ 450,000      
Percentage of pre-tax profit     30.00% 30.00%    
Pre-tax profit     $ 3,333,333      
Payment for rent     127,000   $ 129,000  
Cash services     10,000,000      
Working capital     $ 700,000 ¥ 5,000,000    
Dr. Zhou [Member]            
Commitments and Contingencies [Line Items]            
Cash payment   876,087        
Percentage of pre-tax profit     20.00% 20.00%    
Avactis Biotherapeutics Limited [Member]            
Commitments and Contingencies [Line Items]            
Ownership percentage           60.00%
Arbele Biotherapeutics [Member]            
Commitments and Contingencies [Line Items]            
Ownership percentage           40.00%
Contribution amount     $ 6,660,000      
Avactis Nanjing Biosciences Ltd. [Member]            
Commitments and Contingencies [Line Items]            
Ownership percentage           100.00%
Litigation [Member]            
Commitments and Contingencies [Line Items]            
Cash payment   $ 450,000        
Litigation amount     $ 373,450      
Percentage of pre-tax profit     10.00% 10.00%    
Pre-tax profit     $ 3,333,333      
Common Stock [Member] | Dr. Zhou [Member]            
Commitments and Contingencies [Line Items]            
Shares of common stock (in Shares) | shares   400        
Common Stock [Member] | Litigation [Member]            
Commitments and Contingencies [Line Items]            
Shares of common stock (in Shares) | shares   3,333